Advertisement
Skip to Content

Agilent Technologies Inc A Stock Quote

| Rating as of

NYSE: A

Last close prices updated as of May 26, 2023, 7:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 120.42
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Investment Style Large Growth
  • Day Range 118.38  –  120.72
  • Year Range 112.52  –  160.27
  • Market Cap 35.5239 Bil
  • Volume / Avg 21.0 /  1.7 Mil
  • Price / Sales 5.09
  • Price / Book 6.15
  • Forward Div Yield 0.75%
  • Trailing Div Yield 0.72%

Morningstar‘s Stock Analysis A

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Agilent Earnings: Biopharma Market Uncertainty Pushes Down 2023 Outlook, Despite Strong Period

Julie Utterback Senior Equity Analyst

Analyst Note

| Julie Utterback |

Wide-moat Agilent released second-quarter results that were slightly above expectations, but given ongoing biopharma market uncertainty, management reduced some parts of its 2023 guidance a bit. While we may tinker with our some of our near-term assumptions slightly after this announcement, importantly, management kept guidance intact for the key driver of our $127 fair value estimate—cash flows. Overall, we think Agilent's long-term prospects remain intact, too, and with Agilent shares trading near our current fair value estimate, shares appear to represent a growth at a reasonable price opportunity.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics A

Company Profile A

Business Description

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

Contact
5301 Stevens Creek Boulevard
Santa Clara, CA, 95051
Industry Diagnostics & Research
Employees 18,300

Related Articles A

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of A’s competitive advantage.

Agilent Technologies Inc

XNYS: A

Danaher Corp

XNYS: DHR

Thermo Fisher Scientific Inc

XNYS: TMO

Waters Corp

XNYS: WAT
Price
120.42232.21522.02260.61
Currency
USDUSDUSDUSD
Change
+$0.93 (0.78%) +$1.76 (0.76%) +$1.38 (0.27%) +$1.05 (0.40%)
Market Cap
35.52 Bil171.35 Bil201.35 Bil15.38 Bil
Industry
Diagnostics & Research Diagnostics & Research Diagnostics & Research Diagnostics & Research
Sector
Healthcare
Healthcare
Healthcare
Healthcare

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Agilent Technologies Inc Stock

Yes. A has a forward dividend yield of 0.75%. See A’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

A’s market cap is 35.52 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

A’s stock style is Large Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

A’s price/sales is 5.19.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

A’s price/forward earnings is 27.12.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

A’s price/book is 6.35.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See A’s valuation ratios compared to the Market Index.

A’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare A’s historical performance against its industry peers and the overall market.